Genetic Analysis AS (GEAN)

Currency in NOK
0.70
0.00(0.00%)
Closed·
Unusual trading volume
GEAN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.660.74
52 wk Range
0.532.60
Key Statistics
Bid/Ask
0.70 / 0.71
Prev. Close
0.7
Open
0.71
Day's Range
0.66-0.74
52 wk Range
0.53-2.6
Volume
83.51K
Average Volume (3m)
36.06K
1-Year Change
-14.6341%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GEAN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Buy
Moving Averages
Strong Sell

Genetic Analysis AS Company Profile

Genetic Analysis AS, a science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally. It offers GA-map, a platform for the analysis of the human gut microbiota; GA-map Dysbiosis Test that detects and characterizes dysbiosis; and GA-map Analyzer, a cloud-based software solution. The company also provides GA-map Discovery, a tool to search biomarkers and validate research findings or transfer the findings to a ready-to-use routine testing platform; GA-map Sample Collection Kit used for collection, transport, and storage of fecal specimens for nucleic acid analyses; and GA-map Covid-19 Fecal Test, a non-invasive test with an easy-to-use home sampling procedure. Further, it offers laboratory services; and bioinformatic analysis services. The company develops rapid microbiome-based PCR test. Genetic Analysis AS was founded in 2008 and is headquartered in Oslo, Norway.

Compare GEAN to Peers and Sector

Metrics to compare
GEAN
Peers
Sector
Relationship
P/E Ratio
−5.0x−4.1x−0.6x
PEG Ratio
−0.07−0.110.00
Price/Book
1.6x1.2x2.6x
Price / LTM Sales
2.2x4.2x3.3x
Upside (Analyst Target)
-49.4%44.5%
Fair Value Upside
Unlock17.5%5.0%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Feb 25, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

GEAN Income Statement

FAQ

What Is the Genetic Analysis AS (GEAN) Stock Price Today?

The Genetic Analysis AS stock price today is 0.70 NOK.

What Stock Exchange Does Genetic Analysis AS Trade On?

Genetic Analysis AS is listed and trades on the Spotlight Stock Market.

What Is the Stock Symbol for Genetic Analysis AS?

The stock symbol for Genetic Analysis AS is "GEAN."

What Is the Genetic Analysis AS Market Cap?

As of today, Genetic Analysis AS market cap is 48.36M NOK.

What Is Genetic Analysis AS's Earnings Per Share (TTM)?

The Genetic Analysis AS EPS (TTM) is -0.16.

When Is the Next Genetic Analysis AS Earnings Date?

Genetic Analysis AS will release its next earnings report on Feb 25, 2026.

From a Technical Analysis Perspective, Is GEAN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Genetic Analysis AS Stock Split?

Genetic Analysis AS has split 0 times.

How Many Employees Does Genetic Analysis AS Have?

Genetic Analysis AS has 16 employees.

What is the current trading status of Genetic Analysis AS (GEAN)?

As of Feb 26, 2026, Genetic Analysis AS (GEAN) is trading at a price of 0.70 NOK, with a previous close of 0.70 NOK. The stock has fluctuated within a day range of 0.66 NOK to 0.74 NOK, while its 52-week range spans from 0.53 NOK to 2.60 NOK.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.